https://www.sirius-medical.com/knowledge/breast-biopsy-needle-techniques

Keywords: breast biopsy results, translational research, precision medicine

Breast biopsy results are not only the cornerstone of clinical diagnosis and treatment, but also a key driver in advancing basic research and clinical translation in breast cancer. Each carefully analyzed biopsy sample contains valuable information about tumor biology, providing scientists with continuous resources to explore disease mechanisms, develop new drugs, and optimize therapeutic strategies.

As stated in the materials you provided, breast biopsy needles can obtain tissue samples for "genetic and molecular analysis," serving as a bridge connecting clinical practice with scientific research. Specifically, breast biopsy results hold significant research value at the following levels:

• Revealing tumor heterogeneity and evolution: By analyzing biopsy samples from different sites or time points within the same patient, scientists have discovered that breast cancer is not a homogeneous disease. Within a single tumor, multiple subclones with distinct genetic mutations may coexist, dynamically evolving under therapeutic pressure and developing resistance. This understanding of spatial and temporal tumor heterogeneity, derived from comparative studies of diverse breast biopsy results, provides critical guidance for developing combination therapies to overcome resistance.
• Discovery of novel biomarkers and therapeutic targets: Large-scale genomic, transcriptomic, and proteomic studies rely on high-quality tissue samples. Through association analyses of extensive breast biopsy data, researchers can identify new biomarkers linked to prognosis and treatment response. For example, deep sequencing of biopsies from triple-negative breast cancer patients revealed aberrant activation of pathways such as the androgen receptor (AR) signaling and PI3K/AKT/mTOR in certain patients, leading to clinical trials of targeted drugs.
• Evaluating the efficacy of new drugs and therapies: In early drug development, "window trials" or "neoadjuvant trials" are commonly conducted. In these studies, patients receive experimental drug treatment before surgery, and resected tumor tissues-effectively another form of "biopsy result"-are collected during surgery. By comparing pre- and post-treatment biopsy samples, researchers can directly assess at the molecular level whether the drug hits its intended target and induces the expected biological effects. This pharmacodynamic evidence is crucial in determining whether a new drug advances to the next stage of development.
• Validation and complementation of liquid biopsies: In recent years, liquid biopsy technologies such as circulating tumor DNA (ctDNA) have advanced rapidly, enabling non-invasive monitoring of tumor dynamics through blood tests. However, the accuracy of liquid biopsies must be validated against traditional tissue biopsies. Tissue biopsy results from the same patient and time point serve as the gold standard for assessing the sensitivity and specificity of liquid biopsy methods.

Building precision medicine databases: Linking vast amounts of breast biopsy data-including pathology reports, molecular subtypes, and genetic mutation profiles-with long-term patient outcomes enables the creation of large real-world databases. Using artificial intelligence and big data analytics, researchers can uncover new patterns, such as which combinations of gene mutations indicate an extremely high risk of recurrence or which patient subgroups are particularly responsive to specific chemotherapy regimens.

Each successful breast biopsy not only resolves the immediate diagnostic needs of a patient but also contributes valuable scientific insights to the broader field of breast cancer research. Future precision medicine will increasingly rely on in-depth analysis and multidimensional integration of breast biopsy results. Starting with a small biopsy needle, we are gradually uncovering all the secrets of breast cancer, ultimately aiming for precise prevention, diagnosis, and treatment for every patient.